OACC

Business Context and Reporting Period

This Form 8-K filing by Oaktree Acquisition Corp. III Life Sciences (a Cayman Islands corporation) reports a material corporate event occurring on June 3, 2025. The company is an emerging growth company with securities trading on The Nasdaq Stock Market LLC under the symbols OACCU, OACC, and OACCW.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive personnel changes and does not contain financial performance data.

Material Changes

• Resignation of CFO: Courtney Conigliaro resigned as Chief Financial Officer effective June 3, 2025. The resignation was voluntary to pursue other opportunities and was not the result of any disagreement with the Board or management.
• Appointment of New CFO: Thomas Sweeney was appointed as the new Chief Financial Officer (principal accounting and financial officer) effective immediately on June 3, 2025.
• Audit Committee Update: The Board confirmed Alvin Shih as the chair of the audit committee in connection with the CFO appointment.

Guidance, Outlook, and Management Commentary

Management Commentary on New CFO:

• Mr. Sweeney is a Managing Director within Oaktree Capital Management, L.P.'s finance organization, overseeing accounting, operations, and reporting for the firm's private credit strategy.
• He currently serves as Controller and Assistant Treasurer for Oaktree Specialty Lending Corporation (NASDAQ: OCSL), Oaktree Strategic Credit Fund, and Oaktree Gardens OLP, LLC.
• Mr. Sweeney holds a B.S. in Accounting from the State University of New York at Binghamton and is a Certified Public Accountant in New York.

Compensation and Agreements:

• Mr. Sweeney will not be compensated by the Company for his services as CFO and has not entered into an employment agreement.
• He is expected to enter into an Indemnity Agreement and a Letter Agreement on terms consistent with those of directors and officers from the October 2024 IPO.

Risks and Contingencies: The filing states there are no family relationships between Mr. Sweeney and the Company's directors or officers, and no undisclosed arrangements regarding his appointment.

Investor Verification Checklist

• Verify the transition timeline for financial reporting responsibilities between the outgoing and incoming CFO.
• Confirm the status of the Indemnity Agreement and Letter Agreement for Mr. Sweeney once executed.
• Review the Company's upcoming financial filings to assess the impact of the leadership change on reporting quality and timing.
• Monitor for any future filings regarding the appointment of a permanent, compensated CFO if Mr. Sweeney's role remains interim or pro bono.